St. Johns Investment Management’s Novartis NVS Stock Holding History

St. Johns Investment Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-73	Closed	-$6K	–	173
2018 Q4	$6K	Hold	73	–	–	0.01%	122
2018 Q3	$6K	Hold	73	–	–	﹤0.01%	137
2018 Q2	$5K	Hold	73	–	–	﹤0.01%	149
2018 Q1	$5K	Hold	73	–	–	﹤0.01%	152
2017 Q4	$5K	Hold	73	–	–	﹤0.01%	132
2017 Q3	$6K	Hold	73	–	–	﹤0.01%	155
2017 Q2	$5K	Hold	73	–	–	﹤0.01%	142
2017 Q1	$5K	Hold	73	–	–	﹤0.01%	139
2016 Q4	$5K	Buy	+73	New	+$4.74K	﹤0.01%	142

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

St. Johns Investment Management's NVS Position: Q1 2019 in Review

St. Johns Investment Management sold out of Novartis (NVS) in Q1 2019, closing a stake of 73 shares — an estimated $6K sold.

St. Johns Investment Management first reported a position in NVS in Q4 2016 and held it in 9 quarters. The position peaked at $6K in Q4 2018. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

St. Johns Investment Management reported no remaining Novartis position as of Q1 2019 after selling out during the quarter.
St. Johns Investment Management sold 73 Novartis shares in Q1 2019, an estimated $6K.
St. Johns Investment Management first reported a position in Novartis in Q4 2016 and held it in 9 quarters.
St. Johns Investment Management's Novartis position peaked at $6K in Q4 2018.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on St. Johns Investment Management's 13F filing for Q1 2019, filed 17 Apr 2019.